Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock and American Depositary Receipts
-
Shares outstanding
-
1,226,467,754
-
Total 13F shares
-
257,334,427
-
Share change
-
+4,081,213
-
Total reported value
-
$14,002,947,082
-
Put/Call ratio
-
92%
-
Price per share
-
$54.42
-
Number of holders
-
652
-
Value change
-
+$261,210,757
-
Number of buys
-
345
-
Number of sells
-
227
Institutional Holders of Sanofi - Common Stock and American Depositary Receipts (SNY) as of Q1 2023
As of 31 Mar 2023,
Sanofi - Common Stock and American Depositary Receipts (SNY) was held by
652 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
257,334,427 shares.
The largest 10 holders included
Dodge & Cox, FMR LLC, Boston Partners, Fisher Asset Management, LLC, BANK OF AMERICA CORP /DE/, BlackRock Inc., MORGAN STANLEY, Invesco Ltd., Camber Capital Management LP, and Nuveen Asset Management, LLC.
This page lists
662
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.